Scout Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-57,963
Closed -$18.3M 223
2023
Q1
$18.3M Sell
57,963
-32
-0.1% -$9.6K 0.37% 98
2022
Q4
$16.7M Sell
57,995
-56,701
-49% -$17.3M 0.34% 95
2022
Q3
$33.2M Sell
114,696
-155,620
-58% -$44.8M 0.69% 55
2022
Q2
$76.2M Sell
270,316
-217
-0.1% -$58.1K 1.51% 9
2022
Q1
$70.6M Buy
270,533
+11,775
+5% +$2.79M 1.13% 20
2021
Q4
$56.8M Buy
258,758
+12,385
+5% +$2.41M 0.83% 31
2021
Q3
$44.7M Buy
246,373
+82,519
+50% +$16.1M 0.67% 39
2021
Q2
$33M Buy
+163,854
New +$34.3M 0.49% 70
2016
Q1
Sell
-24,460
Closed -$3.08M 328
2015
Q4
$3.08M Sell
24,460
-45,274
-65% -$5.47M 0.08% 191
2015
Q3
$7.26M Buy
69,734
+17,890
+35% +$2.3M 0.17% 135
2015
Q2
$6.4M Sell
51,844
-92,945
-64% -$11.7M 0.12% 153
2015
Q1
$17.1M Buy
+144,789
New +$17.3M 0.28% 118
2013
Q4
Sell
-93,819
Closed -$7.11M 299
2013
Q3
$7.11M Sell
93,819
-73,775
-44% -$5.87M 0.05% 192
2013
Q2
$13.4M Buy
+167,594
New +$12.3M 0.16% 129

Other funds holding VRTX